A cross-sectional study on autologous: serum skin test in chronic urticaria in a tertiary care centre
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20173924Keywords:
Autoimmune urticaria, ASST, Chronic urticaria, AutoimmunityAbstract
Background: Urticaria persisting daily for more than six weeks is termed as chronic urticaria. A significant number of them have an autoimmune basis, where ASST is used for detection of chronic autoimmune urticaria (CAU). The aim and objective of the study was to determine the frequency of autoimmunity with ASST in chronic urticaria patients.
Methods:This was a hospital based cross sectional study, 100 patients with chronic urticaria fulfilling the inclusion and exclusion criteria were enrolled in the study. Detailed history, physical examination and routine investigations were recorded and ASST was done for all patients.
Results:Thirty seven (37%) out of 100 CU patients were ASST positive. Statistical analysis of the clinical variables did not show significant difference between ASST positive and negative patients except for dermographism and mean duration of the disease.
Conclusions:ASST is a simple invivo clinical test for detection of basophil histamine releasing activity. Diagnosing CAU is important as these patients may need high doses of anti-histamines, systemic corticosteroids and/or immunomodulatory drugs. Autologous serum therapy itself has a therapeutic role in treatment of CAU patients.
References
PS P. Urticaria. Indian J Dermatol Venereol Leprol. 2001;67(1):11.
Poonawalla T, Kelly B. Urticaria: A Review. Am J Clin Dermatol. 2009;10(1):9–21.
Khan S, Maitra A, Hissaria P, Roy S, Anand MP, Nag N, et al. Chronic Urticaria: Indian Context-Challenges and Treatment Options. Dermatol Res Pract. 2013;2013:651737.
Ganguly S, Vikramkumar A, Kuruvila S. Autologous serum skin test as an indicator of chronic autoimmune urticaria in a tertiary care hospital in South India. Indian Dermatol Online J. 2014;5(6):87.
Sharma N, Mahajan V, Vohra S. Autologous serum skin test: Methodology, interpretation and clinical applications. Indian J Dermatol Venereol Leprol. 2009;75(5):545.
Zuberbier T. Classification of urticaria. Indian J Dermatol. 2013;58(3):208.
Al-Hamamy HR, Hameed AF, Abdulhadi AS. Autologous Serum Skin Test as a Diagnostic Aid in Chronic Idiopathic Urticaria. Int Sch Res Not. 2013;2013:e291524.
Ghosh SK, Ghosh S. Autologous Serum Skin Test. Indian J Dermatol. 2009;54(1):86–7.
Stewart GE. Histopathology of chronic urticaria. Clin Rev Allergy Immunol. 2002;23(2):195–200.
Kulthanan K, Jiamton S, Gorvanich T, Pinkaew S. Autologous Serum Skin Test in Chronic Idiopathic Urticaria: Prevalence, Cor-relation and Clinical Implications. Asian Pac J Allergy Immunol. 2006;24(4):201–6.
George M, Balachandran C, Prabhu S. Chronic idiopathic urticaria: comparison of clinical features with positive autologous serum skin test. Indian J Dermatol Venereol Leprol. 2008;74(2):105–8.
Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol. 1999;140(3):446–52.
Vohra S, Sharma N, Mahajan V, Shanker V. Clinicoepidemiologic features of chronic urticaria in patients having positive versus negative autologous serum skin test: A study of 100 Indian patients. Indian J Dermatol Venereol Leprol. 2011;77(2):156–9.
Kurt E, Aktas A, Aksu K, Keren M, Dokumacioglu A, Goss CH, et al. Autologous serum skin test response in chronic spontaneous urticaria and respiratory diseases and its relationship with serum interleukin-18 level. Arch Dermatol Res. 2011;303(9):643–9.
Bakos N, Hillander M. Comparison of chronic autoimmune urticaria with chronic idiopathic urticaria. Int J Dermatol. 2003;42(8):613–5.
Nettis E, Dambra P, D’Oronzio L, Cavallo E, Loria MP, Fanelli M, et al. Reactivity to autologous serum skin test and clinical features in chronic idiopathic urticaria. Clin Exp Dermatol. 2002;27(1):29–31.
Alpay A, Solak Tekin N, Tekin IÖ, Altinyazar HC, Koca R, Çınar S. Autologous Serum Skin Test versus Autologous Plasma Skin Test in Patients with Chronic Spontaneous Urticaria. Dermatol Res Pract. 2013;2013:1–6.
Omalizumab for Chronic Urticaria. N Engl J Med. 2013;368(26):2527–30.
KV G. Autologous serum skin test in chronic idiopathic urticaria. Indian J Dermatol Venereol Leprol. 2004;70(5):283.
Abd El-Azim M, Abd El-Azim S. Chronic autoimmune urticaria: frequency and association with immunological markers. J Investig Allergol Clin Immunol. 2011;21(7):546–50.
Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CEH. EAACI/GA2LEN task force consensus report: the autologous serum skin test in urticaria. Allergy. 2009;64(9):1256–68.
Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, et al. The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Przegl Dermatol. 2015;102(2):155–79.
Krupashankar D, Shashikala K, Madala R. Clinical and investigative assessment of patients with positive versus negative autologous serum skin test: A study of 80 south Indian patients. Indian J Dermatol. 2012;57(6):434.
Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008;122(3):569–73.
O’Donnell BF, Francis DM, Swana GT, Seed PT, Kobza Black A, Greaves MW. Thyroid autoimmunity in chronic urticaria. Br J Dermatol. 2005;153(2):331–5.
